Diagnosis and management of Candida utilis infectious arthritis in a Standardbred filly

A 3‐year‐old Standardbred filly was admitted to the hospital for evaluation and management of previously diagnosed infectious arthritis of the right metacarpophalangeal joint (MCPJ). Candida utilis was isolated from multiple synovial samples submitted for bacterial culture and susceptibility. Following treatment with systemic and intra‐articular fluconazole and regional limb perfusion with amphotericin B and a second arthroscopic debridement the lameness improved and subsequent cultures were negative for bacterial or fungal growth. Infectious fungal arthritis should be a differential diagnosis for atypical or unresponsive joint infections especially in horses previously treated with a combination of intra‐articular corticosteroids and antibiotics.     

Serum antibody response to Mycoplasma hyopneumoniae measured by enzyme-linked immunosorbent assay after experimental and natural infection of pigs

Studies were conducted under experimental and field conditions to determine the effect of infection with M. hyopneumoniae on the immune response in serum as measured by ELISA. Following intratracheal challenge or contact exposure, serologically negative pigs derived from mycoplasma-free piggeries developed an immune response within 10 days. This response continued to rise for a further 50 days. In a field study in a commercial piggery, no animals (0/44) were observed to have M. hyopneumoniae antibodies at day 86 of life. However between day 86 and day 144, 97.7% (42/43) animals sero-converted. These results are discussed in terms of infection spread, particularly in the grower/finisher shed.     

Use of a pool-raft system for recovery of horses from general anesthesia: 393 horses (1984-2000)

OBJECTIVE: To describe the pool-raft recovery system protocol and to evaluate the clinical outcome in horses that underwent recovery from general anesthesia using this system. DESIGN: Retrospective study. ANIMALS: 393 horses that underwent recovery from general anesthesia in the pool-raft system. PROCEDURE: Anesthetic records were examined from horses recovered from anesthesia in the pool-raft system between January 1984 and December 2000. Complete medical records of horses were examined when available. Information regarding the anesthetic and recovery period was recorded. Horses first recovered from general anesthesia in the pool-raft and, once awake, were transported to a recovery stall and lowered to the floor in a standing position. RESULTS: 351 horses underwent 1 pool-raft recovery, and 42 horses underwent multiple pool-raft recoveries. Most horses were recovered from general anesthesia within the pool-raft system to safeguard repair of a major orthopedic injury. During 471 pool-raft recoveries, 34 (7%) horses had complications within the recovery pool and 62 (13%) had complications within the recovery stall. Deaths resulted from complete failure of internal fixation, pulmonary dysfunction, or a combination of pulmonary dysfunction and fixation failure in 2% (10/471) of horses that underwent pool-raft recoveries. CONCLUSIONS AND CLINICAL RELEVANCE: The pool-raft system is a good option for recovery from general anesthesia. Although not a fail-safe system, it appears to decrease the complications of recovering horses in a high-risk category. Potential disadvantages of this system are added expense and manpower necessary in building, maintenance, and usage, as well as size limitations of the raft itself.     

Pharmacokinetics and pharmacodynamics comparison between subcutaneous and intravenous butorphanol administration in horses

The study objective was to compare butorphanol pharmacokinetics and physiologic effects following intravenous and subcutaneous administration in horses. Ten adult horses received 0.1 mg/kg butorphanol by either intravenous or subcutaneous injections, in a randomized crossover design. Plasma concentrations of butorphanol were measured at predetermined time points using highly sensitive liquid chromatography–tandem mass spectrometry assay (LC‐MS/MS). Demeanor and physiologic variables were recorded. Data were analyzed with multivariate mixed‐effect model on ranks (P ≤ 0.05). For subcutaneous injection, absorption half‐life and peak plasma concentration of butorphanol were 0.10 ± 0.07 h and 88 ± 37.4 ng/mL (mean ± SD), respectively. Bioavailability was 87%. After intravenous injection, mean ± SD butorphanol steady‐state volume of distribution and clearance was 1.2 ± 0.96 L/kg and 0.65 ± 0.20 L/kg/h, respectively. Terminal half‐lives for butorphanol were 2.31 ± 1.74 h and 5.29 ± 1.72 h after intravenous and subcutaneous administrations. Subcutaneous butorphanol reached and maintained target plasma concentrations >10 ng/mL for 2 ± 0.87 h (Mean ± SD), with less marked physiologic and behavioral effects compared to intravenous injection. Subcutaneous butorphanol administration is an acceptable alternative to the intravenous route in adult horses.     

Circumcaval ureter associated with an intrahepatic portosystemic shunt in a dog

CASE DESCRIPTION: A 4-month-old Bernese Mountain Dog was examined because of shifting hind limb lameness and lethargy of 2 weeks' duration. CLINICAL FINDINGS: The lameness was attributed to hypertrophic osteodystrophy. Portosystemic shunting was suspected on the basis of low serum albumin concentration and high serum bile acids concentration, and an intrahepatic shunt was identified ultrasono-graphically. Celiotomy was performed, and the shunt was partially closed with a cellophane band. During follow-up ultrasonography 7 months later, dilation of the left renal pelvis and proximal portion of the left ureter was identified. During exploratory celiotomy, the left ureter was found to pass dorsal to the caudal vena cava, and circumcaval ureter was diagnosed. TREATMENT AND OUTCOME: The ureter was transected, repositioned ventral to the vena cava, and anastomosed. Follow-up ultrasonographic examinations revealed gradual resolution of the hydronephrosis and hydroureter. CLINICAL RELEVANCE: Findings suggest that circumcaval ureter should be considered in the differential diagnosis for hydronephrosis and hydroureter in dogs. Partial obstruction of the middle segment of the ureter on ultrasonograms or contrast radiographs should increase the index of suspicion for this condition.